TOP STORY
Johns Hopkins Scientists Discover New Therapeutic Target for Some Breast Cancers 
A protein that pumps calcium out of cells also moonlights as a signal to get massive quantities of calcium to flow in, according to scientists. Their discovery of this surprisingly opposite function, highlights the link between calcium and cancer and holds the promise of a new therapeutic target for certain breast cancers. [Press release from the Johns Hopkins University School of Medicine discussing online prepublication in Cell]
SPECIAL FEATURE
Interested in recruiting talented individuals? Post your career opportunities in Mammary Cell News at no cost. Contact us at info@connexoncreative.com
|
|
CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)
LABORATORY RESEARCH
Store-Independent Activation of Orai1 by SPCA2 in Mammary Tumors
Researchers show that an isoform of secretory pathway Ca2+-ATPase, SPCA2, is upregulated in breast cancer-derived cells and human breast tumors, and suppression of SPCA2 attenuates basal Ca2+ levels and tumorigenicity. [Cell]
miR-378* Mediates Metabolic Shift in Breast Cancer Cells via the PGC-1Beta/ERRGamma Transcriptional Pathway
Here, researchers show that miR-378* expression is regulated by ERBB2 and induces a metabolic shift in breast cancer cells. [Cell Metab]
Cancer Stem Cells From Human Breast Tumors are Involved in Spontaneous Metastases in Orthotopic Mouse Models
To examine the role of breast cancer stem cells in metastasis, researchers generated human-in-mouse breast cancer orthotopic models using patient tumor specimens, labeled with optical reporter fusion genes. [Proc Natl Acad Sci U S A]
Downregulation of Autophagy by Bcl-2 Promotes MCF7 Breast Cancer Cell Growth Independent of Its Inhibition of Apoptosis
Here, by using a loss-of-function mutagenesis study, researchers show that Bcl-2-mediated antagonism of autophagy has a critical role in enhancing the tumorigenic properties of MCF7 breast cancer cells independent of its anti-apoptosis activity. [Cell Death Differ]
Int6 Regulates Both Proteasomal Degradation and Translation Initiation and is Critical for Proper Formation of Acini by Human Mammary Epithelium
Researchers found that, repressing INT6 expression induced transformed properties in normal human mammary epithelium (MCF10A); in contrast, Int6 silencing induced apoptosis in HeLa cells. [Oncogene]
The Normal Mammary Microenvironment Suppresses the Tumorigenic Phenotype of Mouse Mammary Tumor Virus-Neu-Transformed Mammary Tumor Cells
The results indicate that signals emanating from a normal mammary microenvironment, comprised of stromal, epithelial and host-mediated signals, combine to suppress the cancer phenotype during glandular regeneration. [Oncogene]
Cancer Cell Stiffness: Integrated Roles of Three-Dimensional Matrix Stiffness and Transforming Potential
Given the current knowledge base of breast cancer mechanobiology, the findings suggest that there may be a positive relationship among intracellular stiffness sensitivity, cell motility, and perturbed mechanotransduction in breast cancer. [Biophys J]
CLINICAL RESEARCH
High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients
A cohort of 304 estrogen receptor (ER)-positive breast cancer patients was used to investigate the prognostic significance of sphingosine 1-phosphate (S1P) receptors 1, 2, and 3 (ie, S1P1, S1P2, and S1P3), SK1, and extracellular signal-regulated kinase 1/2 expression levels. [Am J Pathol]
Zoledronic Acid Prevents Bone Loss in Premenopausal Women with Early Breast Cancer Undergoing Adjuvant Chemotherapy: A Phase III Trial of the Korean Cancer Study Group (KCSG-BR06-01)
The purpose of this study was to determine whether zoledronic acid could prevent bone loss in premenopausal women undergoing adjuvant chemotherapy for breast cancer. [Breast Cancer Res Treat]
|
|
INDUSTRY NEWS
Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients
Array BioPharma Inc. announced positive interim results of its novel, oral HER2 (ErbB2) inhibitor, ARRY-380, in a Phase I trial in patients with advanced cancer. [Array BioPharma Inc. Press Release]
New Data for Erbitux in Prevalent Cancers to be Revealed at ESMO
Merck Serono, a division of Merck KGaA, Darmstadt, Germany announces that it will be presenting new data from several studies of Erbitux® (cetuximab) in a range of solid tumor types – including the first Phase II data in breast and prostate cancers. [Merck Serono Press Release]
UCD Conway Festival Medal Awarded for Cell Signalling Research
Dr Marc Birtwistle has been awarded the 2010 UCD Conway Festival of Research & Innovation gold medal, sponsored by Roche, for his research to decipher the mechanism cells use to turn on and off biological decisions. [UCD Conway Institute of Biomolecular and Biomedical Research Press Release]
|
|
POLICY NEWS
NIH Grants Will Advance Studies of the Form and Function of Proteins
The National Institutes of Health has awarded 23 grants for structural biology research totaling up to $290 million over five years. [National Institutes of Health, United States]
NCBI Launches the Database of Genomic Structural Variations
The National Institutes of Health announced the launch of a new resource, called the Database of Genomic Structural Variation, or dbVar, to help scientists understand how differences in DNA contribute to human health and disease. [National Institutes of Health, United States]
Lawmakers Introduce Bipartisan Legislation to Create Jobs and Promote Investment in Life Sciences
U.S. Representatives introduced bipartisan legislation that will provide tax incentives for small and mid-sized businesses to invest in life sciences research and development on a targeted basis. The Life Sciences Jobs and Investment Act of 2010 provides an opportunity to enhance medical innovation, life sciences education and job creation in the United States. [House of Representatives, United States]
NIH and FDA Announce Awards to Advance Regulatory Science
The National Institutes of Health will award $9.4 million over three years to support four research projects in regulatory science. This research is conducted in partnership with the U.S. Food and Drug Administration, which will contribute approximately $950,000. [National Institutes of Health, United States]
Tumor Microenvironment Network (TMEN) (U54) (RFA-CA-10-021) [Department of Health and Human Services, United States]
Resource Related Research Projects for Development of Animal Models and Related Materials (R24) (PAR-10-289) [National Center for Research Resources, United States]
Animal and Biological Material Resource Centers (P40) (PAR-11-001) [National Center for Research Resources, United States]
NHLBI Translational Research Implementation Program (TRIP) – Limited Competition – (P50) (RFA-HL-12-003) [National Heart, Lung, and Blood Institute, United States]
Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health; Notice of Meeting (FR Doc. 2010-24548) [National Institutes of Health, United States]
Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-24680) [National Institutes of Health, United States]
Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-24549) [National Institutes of Health, United States]
|
|
EVENTS (Listed by Date)
35th European Society for Medical Oncology (ESMO) Congress
October 8-12, 2010
Milan, Italy
Institute for Genomic Medicine Inaugural Symposium
October 11-12, 2010
San Diego, United States
New York Stem Cell Foundation 5th Annual Translational Stem Cell Research Conference
October 12-13, 2010
New York City, United States
International Symposium on Breast Cancer Prevention: Nutrition, Communications and Public Policy
October 18-19, 2010
West Lafayette, United States
6th Modern Drug Discovery & Development Summit (M3D)
October 20-22, 2010
San Francisco, United States
16th World Congress of the Senologic International Society
October 20-22, 2010
Valencia, Spain
American Institute for Cancer Research (AICR) 2010 Annual Cancer Research Conference
October 21-22, 2010
Washington, DC, United States
MENA Oncology Conference
October 22-23, 2010
Cairo, Egypt
Frontiers in Tumour Progression
October 24-27, 2010
Madrid, Spain
2nd Annual Stem Cells Asia and Regenerative Medicine Congress
October 26-28, 2010
Seoul, Korea
UAE Cancer Congress 2010
October 28-30, 2010
Dubai, United Arab Emirates
6th National Cancer Research Institute (NCRI) Conference
November 7-10, 2010
Liverpool, United Kingdom
9th Annual American Association for Cancer Research (AACR) International Conference: Frontiers in Cancer Prevention Research
November 7-10, 2010
Philadelphia, United States
The 16th International Conference of the International Society of Differentiation: From Stem Cells to Organisms
November 15-18, 2010
Nara, Japan
22nd European Organization for Research and Treatment of Cancer (EORTC)-National Cancer Institute (NCI)-American Association for Cancer Research (AACR) Symposium: Molecular Targets and Cancer Therapeutics
November 16-19, 2010
Berlin, Germany
33rd Annual San Antonio Breast Cancer Symposium
December 8-12, 2010
San Antonio, United States
Epithelial Plasticity and Epithelial to Mesenchymal Transition
January 21-26, 2011
Vancouver, Canada
Select Biosciences 5th Annual Stem Cells World Congress
January 24-25, 2011
San Diego, United States
American Association for Cancer Research (AACR) Stem Cells, Development, and Cancer
March 3-6, 2011
Vancouver, Canada
28th Annual Miami Breast Cancer Conference
March 9-12, 2011
Miami, United States
American Association for Cancer Research (AACR) 102nd Annual Meeting 2011
April 2-6, 2011
Orlando, United States
International Society for Stem Cell Research (ISSCR) 9th Annual Meeting
June 15-18, 2011
Toronto, Canada
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Cell Therapy Technologist (Opexa Therapeutics)
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost.
Visit here to post your career opportunities.
Have we missed an important article or publication in Mammary Cell News? Click here to submit!
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
